Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial
吡咯替尼联合白蛋白结合型紫杉醇作为一线治疗方案，用于治疗既往接受过辅助和/或新辅助曲妥珠单抗治疗的HER2阳性转移性乳腺癌患者的疗效和安全性：一项单臂、II期前瞻性临床试验的I期结果
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.1687
Man, Xiaochu; Huang, Jie; Sun, Shujuan; Zhou, Dongdong; Zhang, Baoxuan; Fang, Shu; Zheng, Fangchao; Li, Chao; Wang, Xinzhao; Huang, Wei; Wang, Linlin; He, Qingqing; Fu, Hui; Zhang, Yan; Liu, Changrui; Dong, Lin; Zhao, Xianguang; Xu, Liang; Sun, Xiao; Fan, Bingjie; Song, Lihua; Zhou, Zhengbo; Yu, Jinming; Li, Huihui
